p53 immunohistochemistry in bladder cancer—a new approach to an old question
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference62 articles.
1. Awakening guardian angels: Drugging the p53 pathway;Brown;Nat Rev Cancer,2009
2. Bladder cancer and p53: An example of what should not be done in biomarker research;Malats;Int J Biol Markers,2000
3. p53 immunohistochemistry as a prognostic marker in bladder cancer: A new toy for urologic scientists?;Schmitz-Dräger;Eur Urol,2000
4. Biological markers in non-muscle-invasive bladder tumors and their prognostic significance;Zlotta;Urol Clin North Am,2000
5. Mutant p53 gain of function: Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy;Blandino;Oncogene,1999
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. 25 years International Bladder Cancer Network (IBCN): The past, the present, and the future;Urologic Oncology: Seminars and Original Investigations;2022-11
2. Immunohistochemical Comparison of p53 Expression, Intensity and Distribution in Different Papillary Urothelial Cancers;Iranian South Medical Journal;2022-05-01
3. Developing Precision Medicine for Bladder Cancer;Hematology/Oncology Clinics of North America;2021-06
4. Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project;Urologic Oncology: Seminars and Original Investigations;2021-05
5. Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy;The Bulletin of Urooncology;2020-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3